Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Call, do not email
Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
Taking appropriate supplements alongside tirzepatide and managing inflammation can help reduce discomfort
Never ignore professional medical advice in seeking treatment because of something you have read on the site
To find out if you qualify, visit the Novo Nordisk Patient Assistance Program website
US$ 29.86
US$ 22.54
US$ 25.28
US$ 23.91
US$ 20.26
US$ 24.21
US$ 28.55
